New Jersey is experiencing an unseasonable early increase in circulating respiratory viruses including Influenza, Rhinovirus/Enterovirus and RSV, in addition to ongoing significant levels of COVID-19.
Clinicians should be aware of these trends and take action to prevent illness and reduce the risks of severe disease and hospitalizations among those who become ill through vaccination, testing and treatment.
Clinicians should be aware of racial and ethnic disparities in COVID-19 treatments as well as in influenza complications and vaccination rates.
Recommended action items along with additional information and resources are included in the attached NJDOH/CDS document as well as the attached CDC HAN from November 4th. The CDC will also be hosting a COCA call entitled "2022-2023 Seasonal Influenza Testing and Treatment During the COVID-19 Pandemic" on November 15th.
This information has been broadcast to: Animal Health Organizations; Animal Health Professionals; Blood Banks; Community Health Centers (FQHCs); Emergency Medical Services / First Responders; EMS Council; Long-term Care; Health Care Facilities / Other; Health Care Organizations; Health Care Providers; Hospital Staff Directory; Hospital CEOs; Hospital Emerg Preparedness Coords; Hospital ER Medical Directors; Hospital Infection Control Practitioners; Hospital Medical Directors; Hospital Nursing Directors; Hospital Patient Safety Liaisons; Hospital Quality Liaisons; Hospital Security Directors; ICU Administrator; Lab Director; Hospitals / Acute Care; Hospitals / Other; Hospitals / Veterans; Labs / Non-Sentinel; Labs / Sentinel; Occupational Health Organizations; Pharmaceutical Suppliers; Health Care Sector; Local Boards of Health; NJDOH Staff; NJLINCS and Local Contacts; NJLINCS Community; Public Health Associations; Public Health Council; Public Health Sector